5:14 PM
 | 
Sep 03, 2009
 |  BC Extra  |  Company News

Pharming resubmits Rhucin MAA

Pharming Group N.V. (Euronext:PHARM) resubmitted an MAA to EMEA for Rhucin recombinant human complement 1 esterase inhibitor (...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >